Education Sessions

E-MG9
Operational and Business Excellence Workshop: Supporting Strategic Initiatives

7 November 09.00-12.00 Track: Manufacturing

ISPE CEUs: 0.3

The pharmaceutical industry is currently undergoing a major business transformation. This is being driven by today’s combination of global regulatory requirements, operational constraints, and growing pressure to reduce the cost of pharmaceuticals to the public. Industry’s transformation is affecting operations across the board.

Listen to case history presentations by Wyeth, Microsoft, Johnson & Johnson, and Genentech. These include a detailed case study of the ongoing Operational Excellence program at Genentech, where the journey to Class A includes the rollout of business process management, ownership of global processes, and process improvement of issues identified through quarterly Class A assessments through
Lean/DMAIC methodologies. Additionally, Wyeth reviews the implementation and deployment of their Six Sigma program using actual examples.

Join in the panel’s discussion on global market and business trends, and how they impact both development and manufacturing operations and performance. Address challenges such as covering industry advancements in technology, the importance of Six Sigma and PAT, and the significance of optimizing operations and measuring performance improvements in real time.

Take Back to Your Job

  • Understand operational and business excellence
  • Use tools and methodologies for implementation and deployment
  • Apply what professionals in the pharmaceutical, biotechnology, and other industries are doing
  • Determine real results and how to measure them

Who Should Attend

Pharmaceutical, biotechnology, contract and generic manufacturers, and anyone from researcher to the engineer, to the vice president of operations and supply chain should attend to learn how industry advances impact business, and how they can implement and sustain programs that develop operational excellence.

Agenda

  • Pharmaceutical Industry Strategy: Enabling People-ready Business in Manufacturing (Microsoft Case Study)
  • More Than a Program for Integrating Control and MES (Johnson & Johnson Case Study)
  • Six Sigma: Friend or Foe (Wyeth Case Study)
  • Operational Excellence Strategic Initiatives (Genentech Case Study)
  • Panel Discussion

 

Session Leaders

Session Speakers

  • Stephen Dinka, Assoc Dir, Corp Eng'g Bus Ops, Genentech
  • Ruediger Dorn, Managing Director of the Worldwide Life Sciences Group, Microsoft
  • Gary Ward, Mgr, Operational Excellence, Wyeth Biotech

Sponsors